Evidence map›Paper›PMID 36980840›Full record

ArticleGenes2023

Genetic Analysis of HIBM Myopathy-Specific GNE V727M Hotspot Mutation Identifies a Novel COL6A3 Allied Gene Signature That Is Also Deregulated in Multiple Neuromuscular Diseases and Myopathies.

Shivangi Attri, Moien Lone, Amit Katiyar, Vikas Sharma, Vinay Kumar, Chaitenya Verma, Suresh Kumar Gahlawat

Open access · goldFull text read
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Shivangi AttriDepartment of Biotechnology, Chaudhary Devi Lal University, Sirsa 125055, India.
Moien LoneDepartment of Biochemistry, All India Institute of Medical Sciences, New Delhi 110029, India.
Amit KatiyarCentralized Core Research Facility, All India Institute of Medical Sciences, New Delhi 110029, India.
Vikas SharmaCentralized Core Research Facility, All India Institute of Medical Sciences, New Delhi 110029, India.
Vinay KumarThe Dorothy M. Davis Heart & Lung Research Institute, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.ORCID 0000-0002-6751-5741
Chaitenya VermaDepartment of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USA.ORCID 0000-0001-5723-6346
Suresh Kumar GahlawatDepartment of Biotechnology, Chaudhary Devi Lal University, Sirsa 125055, India.ORCID 0000-0001-6833-4945
All India Institute of Medical Sciences · INChaudhary Devi Lal University · INThe Ohio State University Wexner Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The GNE-associated V727M mutation is one of the most prevalent ethnic founder mutations in the Asian HIBM cohort; however, its role in inducing disease phenotype remains largely elusive. In this study, the function of this hotspot mutation was profoundly investigated. For this, V727M mutation-specific altered expression profile and potential networks were explored. The relevant muscular disorder-specific in vivo studies and patient data were further analyzed, and the key altered molecular pathways were identified. Our study found that the GNEV727M mutation resulted in a deregulated lincRNA profile, the majority of which (91%) were associated with a down-regulation trend. Further, in silico analysis of associated targets showed their active role in regulating Wnt, TGF-β, and apoptotic signaling. Interestingly, COL6a3 was found as a key target of these lincRNAs. Further, GSEA analysis showed HIBM patients with variable COL6A3 transcript levels have significant alteration in many critical pathways, including epithelial-mesenchymal-transition, myogenesis, and apoptotic signaling. Interestingly, 12 of the COL6A3 coexpressed genes also showed a similar altered expression profile in HIBM. A similar altered trend in COL6A3 and coexpressed genes were found in in vivo HIBM disease models as well as in multiple other skeletal disorders. Thus, the COL6A3-specific 13 gene signature seems to be altered in multiple muscular disorders. Such deregulation could play a pivotal role in regulating many critical processes such as extracellular matrix organization, cell adhesion, and skeletal muscle development. Thus, investigating this novel COL6A3-specific 13 gene signature provides valuable information for understanding the molecular cause of HIBM and may also pave the way for better diagnosis and effective therapeutic strategies for many muscular disorders.

Indexed as

Collagen Type VIMuscular DiseasesApoptosisHumansMultienzyme ComplexesMutationPhenotypeSignal TransductionCOL6A3 protein, humanCollagen Type VIMultienzyme ComplexesUDP-N-acetylglucosamine 2-epimerase - N-acetylmannosamine kinaseCOL6A3GNEHIBMmutationmyopathyncRNAneuromuscular disordersV727M

Identifiers

PMID36980840
PMCPMC10048522
OpenAlexW4322503877

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read30
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.